Eribulin shows high concentration and long retention in xenograft tumor tissues.

about

Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.

P2860

Q55457104-922D04E8-2D77-43FE-AD07-8D3A2AF72BEB

P2860

Eribulin shows high concentration and long retention in xenograft tumor tissues.

Item

http://www.wikidata.org/entity/Q41159925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Eribulin shows high concentration and long retention in xenograft tumor tissues.

@en

type

Item

label

Eribulin shows high concentration and long retention in xenograft tumor tissues.

@en

prefLabel

Eribulin shows high concentration and long retention in xenograft tumor tissues.

@en

P1476

Eribulin shows high concentration and long retention in xenograft tumor tissues.

@en

P2093

Christopher DesJardins

http://www.w3.org/2001/XMLSchema#string

Earvin Liang

http://www.w3.org/2001/XMLSchema#string

Edgar Schuck

http://www.w3.org/2001/XMLSchema#string

Kazutomi Kusano

http://www.w3.org/2001/XMLSchema#string

Krista Condon

http://www.w3.org/2001/XMLSchema#string

Michiko Sugawara

http://www.w3.org/2001/XMLSchema#string

W George Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B

Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions

Membrane transporters in drug development

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

Antimitotic and Non-mitotic Effects of Eribulin Mesilate in Soft Tissue Sarcoma.

Drug delivery and transport to solid tumors.

Eribulin mesylate in patients with refractory cancers: a Phase I study.

Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial.

P2888

s00280-017-3369-7

P304

377-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3369-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090305231

http://www.w3.org/2001/XMLSchema#string

P698

28664226

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5532402

http://www.w3.org/2001/XMLSchema#string

Eribulin shows high concentration and long retention in xenograft tumor tissues.

about

P2860

P2860

Eribulin shows high concentration and long retention in xenograft tumor tissues.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932